Chapters

Transcript

Video

Which T2D patients will be the best candidates for the fixed ratio, combination regimens, i.e., iGlarLixi or iDegLira? And how effective and safe are these formulations at lowering HA1c levels?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Robert Henry, MD

Robert Henry, MD

Chief, Center for Metabolic Research
Chief, Section of Endocrinology, Metabolism & Diabetes
Veterans Affairs Healthcare System
Professor of Medicine‚ Department of Medicine
Division of Endocrinology and Metabolism
University of California‚ San Diego